Activation of NAD(P)H:Quinone Oxidoreductase 1 Prevents Arterial Restenosis by Suppressing Vascular Smooth Muscle Cell Proliferation
Open Access
- 10 April 2009
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation Research
- Vol. 104 (7), 842-850
- https://doi.org/10.1161/circresaha.108.189837
Abstract
Abnormal proliferation and migration of vascular smooth muscle cells (VSMCs) are important pathogenic mechanisms in atherosclerosis and restenosis after vascular injury. In this study, we investigated the effects of β-lapachone (βL) (3,4-Dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran-5,6-dione), which is a potent antitumor agent that stimulates NAD(P)H:quinone oxidoreductase (NQO)1 activity, on neointimal formation in animals given vascular injury and on the proliferation of VSMCs cultured in vitro. βL significantly reduced the neointimal formation induced by balloon injury. βL also dose-dependently inhibited the FCS- or platelet-derived growth factor-induced proliferation of VSMCs by inhibiting G1/S phase transition. βL increased the phosphorylation of AMP-activated protein kinase (AMPK) and acetyl-CoA carboxylase 1 in rat and human VSMCs. Chemical inhibitors of AMPK or dominant-negative AMPK blocked the βL-induced suppression of cell proliferation and the G1 cell cycle arrest, in vitro and in vivo. The activation of AMPK in VSMCs by βL is mediated by LKB1 in the presence of NQO1. Taken together, these results show that βL inhibits VSMCs proliferation via the NQO1 and LKB1-dependent activation of AMPK. These observations provide the molecular basis that pharmacological stimulation of NQO1 activity is a new therapy for the treatment of vascular restenosis and/or atherosclerosis which are caused by proliferation of VSMCs.Keywords
This publication has 34 references indexed in Scilit:
- Requirement for p38 Mitogen-Activated Protein Kinase Activity in Neointima Formation After Vascular InjuryCirculation, 2008
- Energy-dependent regulation of cell structure by AMP-activated protein kinaseNature, 2007
- Catechins inhibit angiotensin II-induced vascular smooth muscle cell proliferation via mitogen-activated protein kinase pathwayExperimental & Molecular Medicine, 2006
- Double blockade of cell cycle progression by coptisine in vascular smooth muscle cellsBiochemical Pharmacology, 2005
- Activation of P38MAPK Signaling Cascade in a VSMC Injury Model: Role of P38MAPK Inhibitors in Limiting VSMC ProliferationEuropean Journal of Vascular and Endovascular Surgery, 2005
- Molecular Regulation of Vascular Smooth Muscle Cell Differentiation in Development and DiseasePhysiological Reviews, 2004
- LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1The EMBO Journal, 2004
- Management of cellular energy by the AMP‐activated protein kinase systemFEBS Letters, 2003
- Vascular Smooth Muscle Growth: Autocrine Growth MechanismsPhysiological Reviews, 2001
- Inducible nitric oxide synthase (iNOS) expression upregulates p21 and inhibits vascular smooth muscle cell proliferation through p42/44 mitogen-activated protein kinase activation and independent of p53 and cyclic guanosine monophosphateJournal of Vascular Surgery, 2000